Brown Brothers Harriman & Co’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$704 Sell
65
-652
-91% -$5.58K ﹤0.01% 1750
2025
Q4
$4.38K Buy
+717
New +$4.28K ﹤0.01% 1546
2022
Q4
Sell
-446
Closed -$5K 1454
2022
Q3
$5K Buy
+446
New +$6.37K ﹤0.01% 1302
2020
Q3
Sell
-125
Closed 1018
2020
Q2
$0 Sell
125
-250
-67% -$862 ﹤0.01% 1153
2020
Q1
$1K Buy
+375
New +$2.43K ﹤0.01% 1031
2019
Q1
Sell
-188
Closed -$2K 1084
2018
Q4
$2K Buy
+188
New +$2.77K ﹤0.01% 857
2018
Q3
Sell
-550
Closed -$10K 872
2018
Q2
$10K Hold
550
﹤0.01% 665
2018
Q1
$10K Hold
550
﹤0.01% 660
2017
Q4
$13K Buy
+550
New +$11.4K ﹤0.01% 722

Other funds holding PTEN

Brown Brothers Harriman & Co's PTEN Position: Q1 2026 in Review

Brown Brothers Harriman & Co reduced its Patterson-UTI (PTEN) stake by 91% in Q1 2026, selling an estimated $5.58K and leaving 65 shares worth $704. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Brown Brothers Harriman & Co first reported a position in PTEN in Q4 2017 and has held it in 9 quarters since. The position peaked at $13K in Q4 2017. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Brown Brothers Harriman & Co held 65 shares of Patterson-UTI worth $704 as of Q1 2026.
  • Brown Brothers Harriman & Co sold 652 Patterson-UTI shares in Q1 2026, an estimated $5.58K.
  • Patterson-UTI made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1750 holding.
  • Brown Brothers Harriman & Co first reported a position in Patterson-UTI in Q4 2017 and has held it in 9 quarters since.
  • Brown Brothers Harriman & Co's Patterson-UTI position peaked at $13K in Q4 2017.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.